Search for: "Double D. Producers, Inc. " Results 161 - 180 of 292
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
23 May 2011, 1:20 pm by WIMS
[*Energy/TarSands]   GET THE REST OF TODAY'S NEWSWaste Information & Management Services, Inc. [read post]
16 Jan 2009, 7:00 am
(IPKat) Benoit Battistelli, director general of France’s INPI, appointed as next chair of EPO Administrative Council (Managing Intellectual Property) European patent trolls feel the heat: Nokia reports IP.com to the European Commission (IAM) Agricultural product quality: MARQUES speaks out (Class 46) European Patent Office to replace corrupt US assignment data (Daily Dose of IP)   Finland Helsinki Court of Appeal denies Akun Tehdas Oy’s appeal and maintains lower court… [read post]
15 Feb 2022, 2:05 pm by Kevin LaCroix
[v] There, GigCapital, a Silicon Valley private equity firm, formed GigCapital 3, Inc. [read post]
4 Apr 2011, 7:37 am by Theo Francis
Even Blankfein’s top-notch driver saw his pay double, as the WSJ noted. [read post]
22 Feb 2012, 6:45 am by Conor McEvily
  And in Marmet Health Care Center, Inc. v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Aug 2012, 10:27 am
 Symptoms of botulism (the illness caused by C. botulinum toxins) include general weakness, dizziness, double-vision, trouble speaking or swallowing, difficulty breathing, muscle weakness, abdominal distention and constipation.If you think you may have botulism, contact your healthcare provider. [read post]
6 Jun 2011, 1:19 pm by WIMS
But the legislation we examine today proposes no innovative solutions to our nation's energy needs; it doubles down on old, ineffective policies. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
21 Jan 2021, 9:06 am by Kristian Soltes
Elizabeth Warren (D-Mass.), who developed the CFPB and is a polarizing figure herself. [read post]
20 Sep 2023, 9:24 am by centerforartlaw
AI can identify the potential for a work to be real or fake, whereas older forms of identification cannot produce a quantifiable percentage of whether a work is real. [read post]
19 Sep 2023, 2:24 pm by centerforartlaw
AI can identify the potential for a work to be real or fake, whereas older forms of identification cannot produce a quantifiable percentage of whether a work is real. [read post]
25 Jun 2013, 1:56 pm by WIMS
Asthma rates have doubled in the past 30 years and our children will suffer more asthma attacks as air pollution gets worse. [read post]
12 Dec 2017, 4:36 pm by Kevin LaCroix
Internet Coin Offerings (ICOs), the method by which startups or other parties can issue cryptographic tokens in an effort to fund or bootstrap a new block chain network, got hit by a double whammy when the U.S. [read post]